Petra Gorombei, PhD, is an Investment Professional at Vensana Capital. Petra brings extensive experience overseeing large-scale global clinical trials and clinical operations to Vensana. Prior to joining Vensana, Petra served as a Clinical Evidence Director at ZOLL Medical, a global medical device company, where she led clinical evidence generation strategies to support new product launches for ZOLL’s cardiac management solutions business. She also spent considerable time in the field engaging with customers and the commercial team, while also supporting due diligence processes for corporate investments and acquisitions. Petra earned her PhD in cancer research from Paris Diderot University and is currently completing an Executive MBA at Duke University’s Fuqua School of Business.